11-22274548-CTTTTT-CT

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_213599.3(ANO5):​c.2236-13_2236-10delTTTT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.116 in 1,266,820 control chromosomes in the GnomAD database, including 7,620 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.11 ( 965 hom., cov: 27)
Exomes 𝑓: 0.12 ( 6655 hom. )

Consequence

ANO5
NM_213599.3 intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.693
Variant links:
Genes affected
ANO5 (HGNC:27337): (anoctamin 5) This gene encodes a member of the anoctamin family of transmembrane proteins. The encoded protein is likely a calcium activated chloride channel. Mutations in this gene have been associated with gnathodiaphyseal dysplasia. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP6
Variant 11-22274548-CTTTT-C is Benign according to our data. Variant chr11-22274548-CTTTT-C is described in ClinVar as [Likely_benign]. Clinvar id is 96678.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-22274548-CTTTT-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.162 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANO5NM_213599.3 linkc.2236-13_2236-10delTTTT intron_variant Intron 19 of 21 ENST00000324559.9 NP_998764.1 Q75V66

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANO5ENST00000324559.9 linkc.2236-20_2236-17delTTTT intron_variant Intron 19 of 21 1 NM_213599.3 ENSP00000315371.9 Q75V66

Frequencies

GnomAD3 genomes
AF:
0.110
AC:
16140
AN:
147036
Hom.:
962
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.166
Gnomad AMI
AF:
0.131
Gnomad AMR
AF:
0.0673
Gnomad ASJ
AF:
0.0653
Gnomad EAS
AF:
0.00138
Gnomad SAS
AF:
0.103
Gnomad FIN
AF:
0.0795
Gnomad MID
AF:
0.0903
Gnomad NFE
AF:
0.101
Gnomad OTH
AF:
0.0968
GnomAD3 exomes
AF:
0.160
AC:
18417
AN:
115060
Hom.:
966
AF XY:
0.164
AC XY:
10132
AN XY:
61940
show subpopulations
Gnomad AFR exome
AF:
0.252
Gnomad AMR exome
AF:
0.102
Gnomad ASJ exome
AF:
0.155
Gnomad EAS exome
AF:
0.00155
Gnomad SAS exome
AF:
0.218
Gnomad FIN exome
AF:
0.117
Gnomad NFE exome
AF:
0.169
Gnomad OTH exome
AF:
0.168
GnomAD4 exome
AF:
0.117
AC:
131055
AN:
1119710
Hom.:
6655
AF XY:
0.117
AC XY:
64590
AN XY:
553250
show subpopulations
Gnomad4 AFR exome
AF:
0.208
Gnomad4 AMR exome
AF:
0.0622
Gnomad4 ASJ exome
AF:
0.0835
Gnomad4 EAS exome
AF:
0.000735
Gnomad4 SAS exome
AF:
0.126
Gnomad4 FIN exome
AF:
0.0877
Gnomad4 NFE exome
AF:
0.121
Gnomad4 OTH exome
AF:
0.117
GnomAD4 genome
AF:
0.110
AC:
16149
AN:
147110
Hom.:
965
Cov.:
27
AF XY:
0.107
AC XY:
7695
AN XY:
71694
show subpopulations
Gnomad4 AFR
AF:
0.166
Gnomad4 AMR
AF:
0.0672
Gnomad4 ASJ
AF:
0.0653
Gnomad4 EAS
AF:
0.00139
Gnomad4 SAS
AF:
0.102
Gnomad4 FIN
AF:
0.0795
Gnomad4 NFE
AF:
0.101
Gnomad4 OTH
AF:
0.0956
Alfa
AF:
0.0424
Hom.:
12

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Jul 17, 2013
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Miyoshi muscular dystrophy 3 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:1
Aug 18, 2019
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Gnathodiaphyseal dysplasia Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Gnathodiaphyseal dysplasia;C1969785:Autosomal recessive limb-girdle muscular dystrophy type 2L Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Autosomal recessive limb-girdle muscular dystrophy type 2L Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs72105710; hg19: chr11-22296094; API